Relief Therapeutics Holding AG

SIX:RLF.SW

2.36 (CHF) • At close May 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CHF.

2024202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 8.4176.0336.0813.321000.56700.0150.25619.4920.714000.38613.7414.54514.8272.48
Cost of Revenue 2.5751.9218.10811.90700.0010.0550.0030.2112.08212.68313.3951.904000000.43
Gross Profit 5.8424.113-12.027-8.5860-0.0010.512-0.003-0.196-1.8266.8077.32-1.90400.38613.7414.54514.8272.05
Gross Profit Ratio 0.6940.682-1.978-2.585000.9030-13.067-7.1310.3490.3530011110.827
Reseach & Development Expenses 1.3571.32812.39319.02413.64500000001.90454.714.54820.14620.17311.2914.677
General & Administrative Expenses 9.24217.2297.7475.652.8380.5660.6430.7040.9050.0282.1920.5133.722.6721.6832.0711.1911.5090
Selling & Marketing Expenses 0.5882.23.3070.3652.6540.3490.3460.9890.0400.030.0660.5561.7963.4033.6322.3513.7620
SG&A 9.8319.42910.8196.9355.4920.9150.9891.2420.9450.0282.2220.584.2764.4675.0875.7033.5415.273.517
Other Expenses 13.5494.184-1.308-0.665-0.161-0.031-0.00600.7921.9651.31218.213-1.686000000
Operating Expenses 24.727114.94124.5226.62419.2980.9460.7881.2421.7371.99320.47718.7934.49459.16719.63425.84823.71416.5628.194
Operating Income -18.885-110.828-36.547-35.21-19.298-0.947-0.5-1.245-16.489-3.819-12.104-11.473-6.18-59.167-19.248-12.108-9.169-1.734-6.143
Operating Income Ratio -2.244-18.37-6.01-10.60200-0.8820-1,099.267-14.911-0.621-0.55400-49.816-0.881-0.63-0.117-2.477
Total Other Income Expenses Net -0.471-0.856-2.276-0.31513.037-11.2150.084-0.656-0.3250-0.017-0.9634.2150.001-0.149-0.114-0.232-0.031-0.869
Income Before Tax -19.356-111.684-54.316-35.525-6.261-12.162-0.416-1.901-16.814-4.367-12.454-12.436-6.485-59.166-19.397-12.222-9.401-1.765-7.012
Income Before Tax Ratio -2.3-18.512-8.932-10.69700-0.7340-1,120.933-17.051-0.639-0.600-50.202-0.889-0.646-0.119-2.827
Income Tax Expense -2.237-13.503-3.526-0.821.567-4.7020.020.9860.02-0.088-0.171-0.217-0.318-0.0010.149-0.0080.2320.2350.2
Net Income -17.119-98.181-50.79-34.705-7.828-7.46-0.436-2.887-16.834-9.154-12.28-12.171-6.485-59.166-19.397-12.214-9.401-2-7.225
Net Income Ratio -2.034-16.274-8.352-10.4500-0.7690-1,122.267-35.743-0.63-0.58800-50.202-0.889-0.646-0.135-2.913
EPS -1.36-8.35-4.8-3.86-1.3-1.42-0.085-0.58-5.32-6.24-10.34-28.41-37.2-343.4-116.67-9.02-7.21-7.67-43.3
EPS Diluted -1.36-8.35-4.8-3.86-1.3-1.42-0.085-0.58-5.32-6.24-10.34-28.41-37.2-343.4-116.67-9.02-7.21-7.67-43.3
EBITDA -16.58-108.202-50.26-32.692-6.092-0.946-0.255-1.733-16.48-0.081-6.022-9.8780.478-57.13-15.381-8.189-4.9771.641-5.574
EBITDA Ratio -1.97-17.935-8.265-9.84400-0.450-1,098.667-0.316-0.309-0.47700-39.808-0.596-0.3420.111-2.247